Sirnaomics’ H1 Loss Widens as Expenses Rise
September 2, 2022
Trending News 🌧️
Sirnaomics Intrinsic Value –
The company’s shares fell 5% in trading today following the release of the results. Sirnaomics($SEHK:02257) attributed the higher expenses to its ongoing clinical trials, as well as increased research and development activities. Given the increase in expenses, it is likely that the company’s losses will widen in the second half of the year. This could put pressure on Sirnaomics’ share price in the near term.
Sirnaomics’ stock opened at $67.5 on Wednesday and closed at $68.8, up by 1.6% from its last closing price of $67.7.
VI Analysis – Sirnaomics Intrinsic Value
A company’s fundamentals are a reflection of its long-term potential. The below analysis on SIRNAOMICS is made simple by the VI app. The intrinsic value of a SIRNAOMICS share is around $77.4, calculated by the VI Line. Now, the SIRNAOMICS stock is traded at $68.8, which is a fair price but still undervalued by 11%.
The company said it expects to continue to incur losses and negative cash flows from operations in the future and will need to raise additional capital to fund its operations.
Leave a Comment